A.M. Galich

1.0k total citations
24 papers, 778 citations indexed

About

A.M. Galich is a scholar working on Oncology, Orthopedics and Sports Medicine and Nephrology. According to data from OpenAlex, A.M. Galich has authored 24 papers receiving a total of 778 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Orthopedics and Sports Medicine and 7 papers in Nephrology. Recurrent topics in A.M. Galich's work include Bone health and treatments (8 papers), Bone health and osteoporosis research (8 papers) and Parathyroid Disorders and Treatments (7 papers). A.M. Galich is often cited by papers focused on Bone health and treatments (8 papers), Bone health and osteoporosis research (8 papers) and Parathyroid Disorders and Treatments (7 papers). A.M. Galich collaborates with scholars based in Argentina, Spain and Belgium. A.M. Galich's co-authors include Manuel Muñoz‐Torres, H. A. P. Pols, Dieter Felsenberg, J Štěpán, Qin-sheng Ge, David A. Hanley, Terence J. Wilkin, A.J.P. Yates, K. Vandormael and Luisa Plantalech and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Bone and Mineral Research and Bone.

In The Last Decade

A.M. Galich

23 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A.M. Galich Argentina 10 539 430 212 196 116 24 778
Borislav Mihov New Zealand 16 640 1.2× 447 1.0× 273 1.3× 203 1.0× 109 0.9× 33 914
Wolfgang Grotz Germany 11 307 0.6× 346 0.8× 35 0.2× 114 0.6× 292 2.5× 18 811
Dacia Cerdá Spain 11 171 0.3× 102 0.2× 61 0.3× 116 0.6× 33 0.3× 42 527
Xavier Surís Spain 12 206 0.4× 98 0.2× 56 0.3× 132 0.7× 40 0.3× 36 446
Andrew D. Bunta United States 14 476 0.9× 185 0.4× 52 0.2× 384 2.0× 21 0.2× 16 633
M.D. Gardner United Kingdom 9 144 0.3× 289 0.7× 62 0.3× 25 0.1× 72 0.6× 20 422
María Dolores Checa Spain 10 45 0.1× 41 0.1× 36 0.2× 168 0.9× 203 1.8× 14 553
Kiyokazu Akioka Japan 11 52 0.1× 62 0.1× 28 0.1× 142 0.7× 62 0.5× 26 405
Marcin Krzanowski Poland 12 33 0.1× 56 0.1× 72 0.3× 44 0.2× 126 1.1× 56 370
Taner Demirci Türkiye 13 17 0.0× 90 0.2× 60 0.3× 79 0.4× 83 0.7× 53 465

Countries citing papers authored by A.M. Galich

Since Specialization
Citations

This map shows the geographic impact of A.M. Galich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A.M. Galich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A.M. Galich more than expected).

Fields of papers citing papers by A.M. Galich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A.M. Galich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A.M. Galich. The network helps show where A.M. Galich may publish in the future.

Co-authorship network of co-authors of A.M. Galich

This figure shows the co-authorship network connecting the top 25 collaborators of A.M. Galich. A scholar is included among the top collaborators of A.M. Galich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A.M. Galich. A.M. Galich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brance, María Lorena, et al.. (2023). Threshold based on bone mineral density for therapeutic decision-making in postmenopausal women and men over 50 years old under glucocorticoid therapy. Reumatología Clínica (English Edition). 19(5). 279–284. 1 indexed citations
2.
Brance, María Lorena, et al.. (2022). Threshold based on bone mineral density for therapeutic decision-making in postmenopausal women and men over 50 years old under glucocorticoid therapy. Reumatología Clínica. 19(5). 279–284. 1 indexed citations
3.
Galich, A.M., et al.. (2021). Normocalcemic primary hyperparathyroidism: 99mTc SestaMibi SPECT/CT results compare with hypercalcemic hyperparathyroidism. Clinical Endocrinology. 96(6). 831–836. 7 indexed citations
4.
Galich, A.M., et al.. (2020). PET/TC 4D 18F-colina en el hiperparatiroidismo: correlación entre datos bioquímicos y parámetros del estudio. Revista Española de Medicina Nuclear e Imagen Molecular. 39(5). 273–278. 3 indexed citations
5.
Bongiovanni, Santiago, et al.. (2020). Is sarcopenia a risk factor for rotator cuff tears?. Journal of Shoulder and Elbow Surgery. 30(8). 1851–1855. 13 indexed citations
6.
Zanchetta, María Belén, et al.. (2020). Hipopara-Red, Real Life Experience in 322 Patients With Hypoparathyroidism. Journal of the Endocrine Society. 5(2). bvaa181–bvaa181. 10 indexed citations
7.
Galich, A.M., et al.. (2020). 18F-choline PET/4D CT in hyperparathyroidism: correlation between biochemical data and study parameters. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition). 39(5). 273–278. 5 indexed citations
8.
Galich, A.M., et al.. (2019). Usefulness of18F-Fluorocholine Positron Emission Tomography–Computed Tomography in Locating Lesions in Hyperparathyroidism. JAMA Otolaryngology–Head & Neck Surgery. 145(8). 743–743. 49 indexed citations
9.
Schurman, León, A.M. Galich, Claudio González, et al.. (2017). [Argentine guidelines for the diagnosis, prevention and treatment of osteoporosis, 2015].. PubMed. 77(1). 46–60. 7 indexed citations
10.
Brun, Lucas R., A.M. Galich, Eduardo A. Vega, et al.. (2014). Strontium ranelate effect on bone mineral density is modified by previous bisphosphonate treatment. SpringerPlus. 3(1). 676–676. 9 indexed citations
11.
Jáuregui, José Ricardo, et al.. (2012). Sarcopenia Una entidad de relevancia clínica actual en adultos mayores. SHILAP Revista de lepidopterología. 32(4). 162–167.
12.
Ferraris, Jorge R., Titania Pasqualini, Guillermo Alonso, et al.. (2010). A study on strategies for improving growth and body composition after renal transplantation. Pediatric Nephrology. 25(4). 753–762. 5 indexed citations
13.
Glerean, Mariela, et al.. (2010). Bone and mineral metabolism in primiparous women and its relationship with breastfeeding: a longitudinal study.. PubMed. 70(3). 227–32. 9 indexed citations
14.
Ferraris, Jorge R., Titania Pasqualini, Guillermo Alonso, et al.. (2007). Effects of deflazacort vs. methylprednisone: a randomized study in kidney transplant patients. Pediatric Nephrology. 22(5). 734–741. 20 indexed citations
15.
Pasqualini, Titania, et al.. (2007). Congenital adrenal hyperplasia clinical characteristics and genotype in newborn, childhood and adolescence.. PubMed. 67(3). 253–61. 8 indexed citations
16.
Belloso, Waldo, et al.. (2003). Agreement Analysis of Variables Involved in Lipodystrophy Syndrome Definition in HIV-Infected Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes. 32(1). 104–111. 17 indexed citations
17.
Sánchez, Ariel, R. C. Puche, Susana Zeni, et al.. (2002). Papel del calcio y de la vitamina D en la salud ósea (Parte I). Conicet. 11(6). 201–217. 8 indexed citations
18.
Ferraris, Jorge R., Titania Pasqualini, Patricia Sorroche, et al.. (2000). Effect of deflazacort versus methylprednisone on growth, body composition, lipid profile, and bone mass after renal transplantation. Pediatric Nephrology. 14(7). 682–688. 39 indexed citations
19.
Pols, H. A. P., Dieter Felsenberg, David A. Hanley, et al.. (1999). Multinational, Placebo-Controlled, Randomized Trial of the Effects of Alendronate on Bone Density and Fracture Risk in Postmenopausal Women with Low Bone Mass: Results of the FOSIT Study. Osteoporosis International. 9(5). 461–468. 480 indexed citations
20.
Vega, Eduardo A., et al.. (1991). Differential action of pamidronate on trabecular and cortical bone in women with involutional osteoporosis. Osteoporosis International. 1(3). 129–133. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Borislav Mihov Breakdown of academic impact, for papers by Wolfgang Grotz Breakdown of academic impact, for papers by Dacia Cerdá Breakdown of academic impact, for papers by Xavier Surís Breakdown of academic impact, for papers by Andrew D. Bunta Breakdown of academic impact, for papers by M.D. Gardner Breakdown of academic impact, for papers by María Dolores Checa Breakdown of academic impact, for papers by Kiyokazu Akioka Breakdown of academic impact, for papers by Marcin Krzanowski Breakdown of academic impact, for papers by Taner Demirci
Rankless by CCL
2026